Literature DB >> 20888545

Modern treatment of infected total knee arthroplasty with a 2-stage reimplantation protocol.

Geoffrey H Westrich1, Sarah Walcott-Sapp, Lindsey J Bornstein, Mathias P Bostrom, Russell E Windsor, Barry D Brause.   

Abstract

The purpose of this study was to determine if 2-stage reimplantation for the treatment of infected total knee arthroplasty (TKA) is still effective for treating contemporary pathogens, many of which are multidrug resistant (MDR). The medical records of all cases of infected TKAs from April 1998 to March 2006 were retrospectively reviewed for data on infecting organism and success of treatment. Of 72 patients (75 knees), with a minimum of 2 years of follow-up, who completed the protocol, the infection was eradicated in 90.7% (68/75 knees). Thirty-one (91.2%) of 34 of MDR infections and 42 (91.3%) of 46 of non-MDR infections were successfully treated. These results support previous studies that demonstrated the effectiveness of a 2-stage reimplantation protocol with a standard 1:8 minimal bactericidal titer for treating infections after TKA, including MDR organisms.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888545     DOI: 10.1016/j.arth.2009.07.017

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

Review 1.  Postoperative infections of the lumbar spine: presentation and management.

Authors:  Dennis S Meredith; Christopher K Kepler; Russel C Huang; Barry D Brause; Oheneba Boachie-Adjei
Journal:  Int Orthop       Date:  2011-12-10       Impact factor: 3.075

2.  The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections.

Authors:  Michael Drexler; Tim Dwyer; Paul R T Kuzyk; Yona Kosashvilli; Mansour Abolghasemian; Gilad J Regev; Assaf Kadar; Tal Frenkel Rutenberg; David Backstein
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-14       Impact factor: 4.342

3.  Management of postoperative spinal infections.

Authors:  Vishal Hegde; Dennis S Meredith; Christopher K Kepler; Russel C Huang
Journal:  World J Orthop       Date:  2012-11-18

Review 4.  [Treatment of periprosthetic infections].

Authors:  L Renner; C Perka; A Trampuz; N Renz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

5.  Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors.

Authors:  Kevin L Garvin; Ryan E Miller; Todd M Gilbert; Anthony M White; Elizabeth R Lyden
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 6.  Arthrodesis should be strongly considered after failed two-stage reimplantation TKA.

Authors:  Chia H Wu; Chancellor F Gray; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176

7.  High infection control rate and function after routine one-stage exchange for chronically infected TKA.

Authors:  Jean-Yves Jenny; Bruno Barbe; Jeannot Gaudias; Cyril Boeri; Jean-Noël Argenson
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

8.  Treatment options in PJI - is two-stage still gold standard?

Authors:  Igor Lazic; Christian Scheele; Florian Pohlig; Rüdiger von Eisenhart-Rothe; Christian Suren
Journal:  J Orthop       Date:  2021-01-20

9.  Is the Proportion of Patients with "Successful" Outcomes After Two-stage Revision for Prosthetic Joint Infection Different When Applying the Musculoskeletal Infection Society Outcome Reporting Tool Compared with the Delphi-based Consensus Criteria?

Authors:  Tracy M Borsinger; Daniel A Pierce; Thomas M Hanson; Paul M Werth; Alexander R Orem; Wayne E Moschetti
Journal:  Clin Orthop Relat Res       Date:  2021-07-01       Impact factor: 4.755

Review 10.  A systematic review of the evidence for single stage and two stage revision of infected knee replacement.

Authors:  James P M Masters; Nicholas A Smith; Pedro Foguet; Mike Reed; Helen Parsons; Andrew P Sprowson
Journal:  BMC Musculoskelet Disord       Date:  2013-07-29       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.